Cart summary

You have no items in your shopping cart.

Miransertib mesylate

SKU: orb1739328

Description

Miransertib mesylate is a non-ATP competitive, selective AKT inhibitor that suppresses the PI3K/AKT pathway. This inhibition can impede tumor cell proliferation and promote apoptosis, as demonstrated in cellular assays and in vivo models of cancers like Proteus syndrome and various carcinomas.

Images & Validation

Key Properties

CAS Number1817727-88-0
MW624.73
FormulaC29H32N6O6S2
SMILESCS(O)(=O)=O.CS(O)(=O)=O.Nc1ncccc1-c1nc2ccc(nc2n1-c1ccc(cc1)C1(N)CCC1)-c1ccccc1
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • MeTC7 [orb1739329]

    99.69% (May vary between batches)

    1817841-22-7

    618.65

    C32H48BrN3O4

    5 mg, 1 mg, 10 mg, 100 mg, 50 mg, 25 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Miransertib mesylate (orb1739328)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%